Skip to content

Pediatric Aggression and Violence

Salivary Hormones and Pediatric Aggression and Violence: A Feasibility Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01253343
Enrollment
17
Registered
2010-12-03
Start date
2011-09-30
Completion date
2012-11-30
Last updated
2013-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Aggression and Violence

Brief summary

Violence and aggression on pediatric psychiatry units has led to staff and patient injuries and even deaths around the country. In an effort to improve safety, the investigators have developed a method (with the Brief Rating of Child and Adolescent Aggression) of identifying children and adolescents at a higher risk for aggression and violence on the units. In order to improve this prediction, the investigators plan to study salivary hormones in low risk children and high risk children. The salivary hormones to be studied include cortisol, testosterone, and dehydroepiandrosterone sulfate (DHEAS). The investigators expect to improve the investigators current ability to predict the severity and type of pediatric aggression and violence on the inpatient units by combining information from the Brief Rating of Child and Adolescent Aggression (BRACHA), the Predatory-Affective Aggression Scale (Vitiello et al., 1990), and salivary hormones.

Interventions

None listed

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
7 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

1. Prepubescent males (per parent report), African American or Caucasian, between 7 and 9 years old 2. Ability of the subject to provide assent 3. Ability of the guardian to give parental permission 4. Completion of the BRACHA questionnaire 5. Completion of the Predatory-Affective Aggression Scale (PAAS)

Exclusion criteria

1. Viral or bacterial infection or treatment with antibiotics within two weeks of screening 2. Recent surgery (within 8 weeks of screening) 3. Bleeding gums (within 8 weeks of screening) 4. Currently detained in a juvenile detention 5. Currently taking medications such as antipsychotic medications (besides Aripiprazole), steroids and beta adrenergic agonists that affect hormones 6. If it is the investigator's clinical judgment that the subject should be excluded if it is in the subject's best interest or due to any other factor that may interfere with study results

Design outcomes

Primary

MeasureTime frameDescription
Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) ScoreCollected on one or two daysWe collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization.
Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.Collected on one or two daysWe collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization.

Countries

United States

Participant flow

Recruitment details

Between May 2011 and November 2011, we recruited 17 psychiatrically hospitalized boys (ages 7 to 9 years). We categorized the 17 participants into 2 groups, high aggression risk and low aggression risk, based on their initial BRACHA score.

Pre-assignment details

Inclusion criteria included boys aged 7 to 9 years, with BRACHA scores, admitted to a psychiatric inpatient unit. Exclusion criteria included presence of infection requiring antibiotics within 2 weeks, recent surgery within 8 weeks, bleeding gums within 8 weeks of admission, current detainment in juvenile detention, and steroid use.

Participants by arm

ArmCount
Inpatient High Aggression
The high- risk group was defined as having a BRACHA score ≥ 8.
9
Inpatient Low Aggression
The low- risk group was defined as having a BRACHA score ≤6.5.
8
Total17

Baseline characteristics

CharacteristicInpatient Low AggressionInpatient High AggressionTotal
Age, Categorical
<=18 years
8 Participants9 Participants17 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous8 years
STANDARD_DEVIATION 1
8 years
STANDARD_DEVIATION 1
8 years
STANDARD_DEVIATION 1
Region of Enrollment
United States
8 participants9 participants17 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
8 Participants9 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score

We collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization.

Time frame: Collected on one or two days

Population: The number of participants for analysis was supposed to be 24 based on Kelsey's sample size calculation (Kelsey et al., Methods in Observational Epidemiology, 2nd Edition, Table 12-15). However, due to funding constraints we only collected samples from 17 participants.

ArmMeasureValue (MEAN)Dispersion
Low Aggression Group + Cortisol Sample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.8 ul/dLStandard Deviation 0.9
Low Aggression Group + Cortisol Sample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.4 ul/dLStandard Deviation 0.1
Low Aggression Group + Cortisol Sample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.3 ul/dLStandard Deviation 0.3
High Aggression Group + Cortisol Sample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.4 ul/dLStandard Deviation 0.2
High Aggression Group + Cortisol Sample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.8 ul/dLStandard Deviation 0.3
High Aggression Group + Cortisol Sample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score0.2 ul/dLStandard Deviation 0.1
Primary

Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.

We collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization.

Time frame: Collected on one or two days

Population: The number of participants for analysis was supposed to be 24 based on Kelsey's sample size calculation (Kelsey et al., Methods in Observational Epidemiology, 2nd Edition, Table 12-15). However, due to funding constraints we only collected samples from 17 participants.

ArmMeasureValue (MEAN)Dispersion
Low Aggression Group + Cortisol Sample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.85.7 pg/mLStandard Deviation 30.9
Low Aggression Group + Cortisol Sample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.121.1 pg/mLStandard Deviation 64.4
Low Aggression Group + Cortisol Sample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.111.9 pg/mLStandard Deviation 45.8
High Aggression Group + Cortisol Sample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.37.3 pg/mLStandard Deviation 8.2
High Aggression Group + Cortisol Sample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.38.8 pg/mLStandard Deviation 16.5
High Aggression Group + Cortisol Sample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.42.7 pg/mLStandard Deviation 14.4
High Aggression Group + DHEASample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.97.3 pg/mLStandard Deviation 95.1
High Aggression Group + DHEASample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.132.3 pg/mLStandard Deviation 101.6
High Aggression Group + DHEASample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.95.5 pg/mLStandard Deviation 58.2
High Aggression Group + TestosteroneSample1Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.45.1 pg/mLStandard Deviation 25.8
High Aggression Group + TestosteroneSample2Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.46.9 pg/mLStandard Deviation 17.8
High Aggression Group + TestosteroneSample3Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score.37 pg/mLStandard Deviation 12.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026